Rapport Therapeutics
Trade Rapport Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About RAPP
Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform.
RAPP Key Statistics
Stock Snapshot
As of today, Rapport Therapeutics(RAPP) shares are valued at $45.77. The company's market cap stands at 2.19B, with a P/E ratio of -15.05.
On 2026-09-06, Rapport Therapeutics(RAPP) stock moved within a range of $45.53 to $48.00. With shares now at $45.77, the stock is trading +0.5% above its intraday low and -4.6% below the session's peak.
Trading activity shows a volume of 273.93K, compared to an average daily volume of 290.2K.
The stock's 52-week range extends from a low of $14.21 to a high of $52.93.
The stock's 52-week range extends from a low of $14.21 to a high of $52.93.
Analyst ratings
100%
of 13 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.